Shares in medical firm Smith & Nephew leapt on Tuesday as ongoing restructuring delivered strong full-year sales and profits. At £11.37 per share, Smith & Nephew’s share price was 9% higher on ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of a comprehensive foot & ankle repair portfolio in Australia and New Zealand (ANZ) with ...

Smith & Nephew will produce its full-year results on Tuesday 25 February, following a year where share price has dropped by a tenth. In the past five years, the orthopaedic implant and sports medicine ...

After hours: March 5 at 4:05:07 PM EST ...

We believe the UK small-cap market offers a myriad of opportunities across a wide range of different businesses and industries.

Smith+Nephew has reported a rise in profits in its full-year results with the historic medical equipment manufacturer saying it had "made solid progress fixing the foundations" of the business. The ...

Smith & Nephew, the powerhouse behind hip replacements, has seen profits soar after a resurgence in its US arm. The FTSE 100-listed med-tech giant has been in the midst of a corporate overhaul and ...

It makes sense then that Smith+Nephew, a specialist in advanced wound care and sports medicine, has said it will sponsor tennis players participating in this year’s Wimbledon championships ...

The medical equipment firm makes knee and hip replacements (Stuart Johnson/University of Bristol/PA) Profits at hip replacement making giant Smith & Nephew have jumped after a rebound in its US ...